2y37
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | == | + | ==The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS)== |
<StructureSection load='2y37' size='340' side='right' caption='[[2y37]], [[Resolution|resolution]] 2.60Å' scene=''> | <StructureSection load='2y37' size='340' side='right' caption='[[2y37]], [[Resolution|resolution]] 2.60Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| Line 20: | Line 20: | ||
</div> | </div> | ||
<div class="pdbe-citations 2y37" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 2y37" style="background-color:#fffaf0;"></div> | ||
| - | |||
| - | ==See Also== | ||
| - | *[[Nitric Oxide Synthase|Nitric Oxide Synthase]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 07:33, 17 January 2018
The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS)
| |||||||||||
Categories: Lk3 transgenic mice | Andrews, G | Beaton, H G | Birkinshaw, T N | Boughton-Smith, N | Cheshire, D R | Connolly, S | Cook, T R | Cooper, A | Cooper, S L | Cox, D | Dixon, J | Gensmantel, N | Hamley, P J | Harrison, R | Hartopp, P | Kack, H | Luker, T | Mete, A | Millichip, I | Nicholls, D J | Pimm, A D | St-Gallay, S A | Wallace, A V | Drug design | Oxidoreductase
